ARTIRIA’s mission is to help to reduce the mortality and morbidity after a stroke. With our straight forward, minimally invasive approach, we want to solve a strong unmet medical need. Exploiting ongoing innovation with the high standards of Swiss quality, Artiria aims to lead in the development of the next-generation products for endovascular surgeons.
of continued clinical feedback collected
of work experience in Medtech cumulated in the team
spent on stress-testing our technology
to keep the team motivated
We work with a team
Artiria Medical was founded in 2019 by Guillaume and Marc as a spinoff of the Swiss Federal Institute of Technology Lausanne (EPFL). Based in Switzerland, Artiria’s team is composed of entrepreneurial professionals with mechanical, medical and industrial Medtech experience.
At Artiria Medical, we are highly grateful for all the support received from our partners.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 886909.